The National Football League (NFL) wants to know more about cannabis as a pain reliever, and it’s willing to put up an initial US$1 million for research.

Also this week, a cannabis operator announced plans to buy assets from a languishing producer.


Keep reading to find out more cannabis highlights from the past five days.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

NFL pursuing more cannabis information

On Tuesday (June 8), the NFL announced it will dedicate US$1 million to research on using cannabinoids for pain relief. The move was made through the organization’s pain management committee, which is run in collaboration with the NFL Players Association.

“There is a need for better information, better science,” Dr. Allen Sills, the NFL’s chief medical officer, said.

The league confirmed it has engaged players to hear about the use of cannabis for pain relief. Previously the drug was an unsanctioned substance in the eyes of the league.

This week’s news is a stepping stone in the NFL’s decision to adjust its views in regards to cannabis, and comes as drug policy continues to change in the US.

The league said the US$1 million earmarked will be given through up to five grants, which will be sent out near the Thanksgiving holiday.

Operator buys facility from fellow Canadian company

Cannara Biotech (TSXV:LOVE,OTCQB:LOVFF) said it will be buying a Valleyfield, Quebec, facility from the Green Organic Dutchman Holdings (TGOD) (TSE:TGOD,OTCQX:TGODF) for C$27 million.

In addition to the initial sum, Cannara will also set up deposit requirements of roughly C$5.7 million. Cannara will pursue a non-brokered private placement to complete the deal.

Zohar Krivorot, president and CEO of Cannara, said the purchase represents a strengthening of the company’s presence in Quebec, its home province.

Cannara CFO Nicholas Sosiak said the purchase will boost the company’s annual output, profitability and overall financial position. He remarked that the deal was fueled by the company’s “confidence in the broader market for competitively priced premium-grade cannabis products and our intention to capture a significant share of it.”

Cannabis company news

  • Planet 13 Holdings (CSE:PLTH,OTCQB:PLNHF) collected $11.2 million in sales in May as the company celebrates a steady return to pre-pandemic numbers. “We remain confident about the continuation of this upward trend as Las Vegas reopens to its full potential as well as the upcoming opening of our Orange County SuperStore in July,” Larry Scheffler, co-CEO of Planet 13, said.
  • Halo Collective (NEO:HALO,OTCQX:HCANF) confirmed a new partnership with Elegance Brands, a beverage maker, to pursue the development of a cannabis-infused drink line. “Elegance Brands has created a unique and exciting portfolio of THC products, and with this Transaction, we step into one of the fastest-growing segments of the functional beverage market,” Halo CEO Kirin Sidhu said.
  • Aurora Cannabis (NASDAQ:ACB,TSX:ACB) launched three new dried flower product SKUs as part of its San Rafael ’71 branded lineup. The new items are Stonefruit Sunset, Lemon Rocket and Driftwood Diesel.
  • Trulieve Cannabis (CSE:TRUL,OTCQX:TCNNF) informed shareholders it has completed its acquisition plan for Solevo Wellness West Virginia, an operator based in West Virginia that holds three dispensary permits, for a total sum of US$650,000.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

If you own shares in any of the companies listed above and
would like to discuss our investigations or have any questions concerning
this notice or your rights or interests, please contact:

Keep reading... Show less

THC-O-Acetate to be Produced Through Company’s Specialty Molecule Division

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf”, “OILS”, or the “Company”), an extraction company that owns one of the largest portfolios of U.S. patents for the extraction and distillation of cannabinoids, is pleased to announce the launch of a Specialty Molecules Division to focus on the development and commercialization of novel psychoactive compounds. The division is supported by the Company’s existing intellectual property (“IP”) portfolio, including the manufacturing of CBD-O-acetate and the recently announced U.S. patent for the synthesis of THC-O-acetate.

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (the “Company”) is pleased to announce that it has completed construction of an industrial-grade distribution site and launched third party distribution services.

As part of its Phase 1 Construction project at the 196,000 square foot facility, the Company has built out 16,000 square feet of retail-ready product storage space, installed automated, assembly-line style packaging equipment for jar and pouch production, and built out a climate-controlled area that can store 30 tractor-trailer loads of cannabis and 230 pallets positions of -40 degree Fahrenheit freezers for storing live resin and live resin products. A secure loading bay and a small in-house fleet of refrigerated trucks is also in place.

Keep reading... Show less

Global Wellness Strategies Inc. (CSE: LOAN) (FSE: O3X) (OTCQB: PNNRF) (formerly Redfund Capital Corp.) (“GWS” or the “Company”) is pleased to provide the following corporate update highlights on two portfolio clients KaleidoMyco LLC and Biominerales Pharma Corp. and announces the signing of the one-stop digital marketing team of North Equities Corp.

“With the talent, skills and resources we have at Global Wellness, we are well positioned to develop leading nutraceutical product portfolio brands focused on health and well-being. As hemp-extract and psilocybin is legalized in more jurisdictions such as Oregon where we already have a strong strategic relationship, we can then easily extend our existing product range, which will already have established routes to market and brand recognition, to include myco-dosing products. KaleidoMyco products will be in stores and on a consumer digital platform in the USA shortly and is currently being consumer tested in Europe as well. Our shareholders and customers are extremely important to us and we look forward to meeting the milestones we have outlined with the help of North Equities,” said Meris Kott, CEO.

Keep reading... Show less

VINIA(R)’s ability to increase dilation of arteries and to reduce blood vessel constriction allows it to fight the human aging process

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) announces that its flagship VINIA® product is the only dietary supplement available in the US market which has the capability for both reducing the endothelin 1 (ET1) enzyme as well as increasing the nitric oxide (NO) molecules, in order to increase the dilation of arteries and thereby improve blood flow. The presence of ET1 constricts the blood vessel, whereas the presence of NO dilates it. As a result of its “double-action” effect (proven by the Flow Mediated Dilatation (FMD) measurements in a double-blinded Placebo-controlled clinical trial*and in an in-vitro study** whose results were both published), VINIA® is uniquely positioned to combat the aging process caused by a reduction in blood flow.

Keep reading... Show less